Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note published on Wednesday. The firm issued a sell rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Performance

STRM stock opened at $2.94 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. The stock has a market capitalization of $12.41 million, a price-to-earnings ratio of -0.56 and a beta of 1.67. Streamline Health Solutions has a 1 year low of $1.85 and a 1 year high of $9.75. The stock’s fifty day moving average is $2.62 and its two-hundred day moving average is $5.29.

Streamline Health Solutions (NASDAQ:STRM) last posted its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.